N-Hydroxyphthalimide
Based on 1 Customer Validation
N-Hydroxyphthalimide is a blocking agent and catalyst. N-Hydroxyphthalimide promotes oxidation reactions by generating PINO free radicals and activating hydrogen atom transfer processes. N-Hydroxyphthalimide reduces the expression of anti-apoptotic proteins Survivin and Bcl-xL and activates caspase 9 and caspase 3. N-Hydroxyphthalimide induces Apoptosis. N-Hydroxyphthalimide inhibits the phosphorylation of mTOR (Ser2448, Ser2481) and Akt (Ser473). N-Hydroxyphthalimide has anticancer effects against breast and colon cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.63%
- CAS No.: 524-38-9
- Formule: C8H5NO3
- Masse moléculaire:163.13
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform Caspase
More
Activité biologique
|
Caspase 9 |
Caspase 3 |
Bcl-xL |
N-Hydroxyphthalimide (2.5-40 μM; 24-72 h) selectively inhibits the proliferation of human breast carcinoma BT-20 cells, human colon adenocarcinoma LoVo and HT-29 cells by inducing G2/M phase arrest and apoptosis[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Decreased the expressions of anti-apoptotic proteins survivin and Bcl-xL.
Activated caspase 9 and caspase 3.
BT-20, LoVo cells -
Concentration:2.5 μM, 5 μM, 10 μM, 20 μM
-
Incubation Time:24 h
-
Result:Decreased the expressions of anti-apoptotic proteins survivin and Bcl-xL.
Activated caspase 9 and caspase 3.
Suppressed the phosphorylation of mTOR (Ser2448, Ser2481).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Three-week old female BALB/c nude mice; human breast carcinoma BT-20 cell xenograft model[3]
-
Dosage:40 mg/kg
-
Administration:Intraperitoneal injection; 53 days (started when tumor volume reached approximately 100 mm3)
-
Result:Significantly reduced tumor volume and tumor weight.
Achieved a 53% tumor growth inhibition rate.
Decreased the tumor weight by 45%.
Decreased the phosphorylation levels of mTOR at Ser2448, S6 at Ser235/236, 4E-BP1 at Ser65, and Akt at Ser473.
Chemical Information
-
CAS No. 524-38-9
-
Appearance Solid
-
Masse moléculaire 163.13
-
Formule C8H5NO3
-
Color White to yellow
-
SMILES
O=C1C2=C(C(N1O)=O)C=CC=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
DMSO : 100 mg/mL (613.01 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 6.1301 mL | 30.6504 mL | 61.3008 mL | 153.2520 mL |
| 5 mM | 1.2260 mL | 6.1301 mL | 12.2602 mL | 30.6504 mL | |
| 10 mM | 0.6130 mL | 3.0650 mL | 6.1301 mL | 15.3252 mL | |
| 15 mM | 0.4087 mL | 2.0434 mL | 4.0867 mL | 10.2168 mL | |
| 20 mM | 0.3065 mL | 1.5325 mL | 3.0650 mL | 7.6626 mL | |
| 25 mM | 0.2452 mL | 1.2260 mL | 2.4520 mL | 6.1301 mL | |
| 30 mM | 0.2043 mL | 1.0217 mL | 2.0434 mL | 5.1084 mL | |
| 40 mM | 0.1533 mL | 0.7663 mL | 1.5325 mL | 3.8313 mL | |
| 50 mM | 0.1226 mL | 0.6130 mL | 1.2260 mL | 3.0650 mL | |
| 60 mM | 0.1022 mL | 0.5108 mL | 1.0217 mL | 2.5542 mL | |
| 80 mM | 0.0766 mL | 0.3831 mL | 0.7663 mL | 1.9157 mL | |
| 100 mM | 0.0613 mL | 0.3065 mL | 0.6130 mL | 1.5325 mL |
N-Hydroxyphthalimide Related Classifications
HY-Y0396 Related Classifications
Powered by Bioz